abrdn Healthcare Investors

Overview

abrdn Healthcare Investors is a closed-end fund that invests in public and private companies within the healthcare sector, including biotechnology, medical devices, and pharmaceuticals. The fund primarily focuses on growth equities, particularly small-cap companies, employing fundamental analysis to assess market position, management quality, technological expertise, and financial capacity. The fund's investment strategy involves a diversified approach across various healthcare industries, aiming to capitalize on emerging opportunities and innovations. It seeks to provide investors with exposure to a broad spectrum of healthcare companies, from established firms to promising startups. As of October 27, 2023, abrdn Inc. assumed management of the fund, bringing its global investment expertise and resources to enhance the fund's performance and operational efficiency. The fund continues to trade on the New York Stock Exchange under the ticker symbol HQH, maintaining its commitment to delivering value to shareholders through strategic investments in the dynamic healthcare sector.

Investment Focus

• Accredited Investors
• Investment Horizon: 5+ years
• Risk Tolerance: High
• Knowledge of Healthcare Industry

Portfolio Companies